The American College of Obstetricians and Gynecologists (ACOG) issued an opinion today recognizing the problematic complications associated with the use of mesh for pelvic organ prolapse surgery. ACOG opines that pelvic mesh use "should be reserved for high-risk women for whom the benefit may justify the risk." As the scientific community and the FDA is now pointing out, those risks include risks not present in traditional surgical techniques such as mesh erosion and vaginal scarring and shrinkage caused by mesh implants. Further, as pointed out in the ACOG opinion, if mesh is causing complications, complete removal of the mesh is sometimes impossible, making the painful complications exist for an indefinite period of time.
The incidence of POP is beginning to grow, so it is now more important than ever to ensure that it is properly treated, and that greedy device manufacturers represent the truth about their products and the dangerous complications that are associated with mesh products. Dr. Iglesia, former Chair of the College's Committee points out that "in many cases, POP can be successfully treated without mesh and women and their doctors really need to weigh the risks and benefits before deciding on a course of action."
Learn more about Transvaginal Mesh Lawsuit